HROW · NASDAQ · Drug Manufacturers - Specialty & Generic

Harrow (HROW)

Commercializes branded eye medicines and ImprimisRx compounding for US ophthalmology.

$33.47
vs last close−0.98 (−2.84%)
  1. Harrow: Now Is The Buy Time

    Seeking Alpha